[Translated article] Impact of pharmaceutical care on adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia
Adherence is one of the most relevant parameters in the effectiveness of chronic treatments. Approximately half of our CML patients showed inadequate adherence to TKIs. This is the first prospective study to determine that the pharmacist's actions in oncohaematology-specific outpatient units of the Pharmacy Services are capable of influencing adherence and improving it.
Authors
- Gloria Julia Nazco Casariego
- Carolina Alarcón-Payer (ORCID: https://orcid.org/0000-0001-5836-1050)
- Betel Del Rosario García (ORCID: https://orcid.org/0000-0002-7786-980X)
- Fernando Gutiérrez Nicolás
- Leonor Oliva Oliva
- Virginia González Rosa
- María Micaela Viña Romero
Institutions
- Hospital Universitario de Canarias (ES)
- Hospital Universitario Nuestra Señora de Candelaria (ES)
- Hospital Universitario de Gran Canaria Doctor Negrín (ES)
- Hospital Universitario Virgen de las Nieves (ES)
- Hospital Jerez Puerta del Sur (ES)
Publication Details
- Journal
- Farmacia Hospitalaria
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1016/j.farma.2025.03.018
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00